课题基金 / 基金详情

Improved anti-counterfeiting techniques to confound modern scanners and photocopiers and safeguard medical prescriptions

Improved anti-counterfeiting techniques to confound modern scanners and photocopiers and safeguard medical prescriptions
改进的防伪技术可混淆现代扫描仪和复印机并保护医疗处方
批准号:
492072-2015
负责人:
Hamam, Habib
金额:
$1.82万
依托单位:
依托单位国家:
加拿大
项目类别:
Engage Grants Program
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Hamam, Habib的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is a need to protect original documents in order to distinguish them from forgeries or fraudulent duplications. For example, it is illegal to photocopy prescriptions provided by doctors and present them as original documents to pharmacists. A variety of techniques are currently employed to produce original papers that cannot be photocopied or scanned without alteration. Rx Security uses void pantographs which remain one of the most efficient methods and least expensive technologies. Recent developments in photocopying and scanning technologies have made void pantographs less and less effective. This is because the imaging system of the photocopier is not behaving as a "low-pass filter" anymore. Thus the word "void", "copy" or "invalid" does not appear anymore in the photocopy or scanned version of the document as required by the anti-counterfeiting standards which govern the clients' marketplace. RX Security has approached the Université de Moncton to provide a research based solution to the problem of increasingly sophisticated photocopiers and scanners as it relates to their product line and anti-forgery techniques. The research challenges are as follows: 1) Recently the optical performance of the photocopiers and scanners became almost as good as the performance of the system of the eye and sometimes even better. We should research a solution that challenge this high performance of today's photocopiers and scanners, however the verification should be doable by the eye or a commonly used technology (telephones for example). 2) The solution should be fluidly and seamlessly implementatble by the company using it's current production capacities and equipment. As well, departures into new and alternative anti-duplication technologies would imply more direct competition with well-established competitors. 3) Since the photocopiers and scanners became optically high performing (less filtering), the solution could integrate high performing components, and therefore it is expected to introduce more expenses. However, the solution should not be expensive. 4) The current production standards (color of the front side, font, graphical inclusions, etc) must be respected.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protection des documents originaux contre le photo-copiage et la numérisation
  • 批准号:
    RGPIN-2017-05096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2022
  • 负责人:
    Hamam, Habib
  • 依托单位:
Protection des documents originaux contre le photo-copiage et la numérisation
  • 批准号:
    RGPIN-2017-05096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2021
  • 负责人:
    Hamam, Habib
  • 依托单位:
Protection des documents originaux contre le photo-copiage et la numérisation
  • 批准号:
    RGPIN-2017-05096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2020
  • 负责人:
    Hamam, Habib
  • 依托单位:
Protection des documents originaux contre le photo-copiage et la numérisation
  • 批准号:
    RGPIN-2017-05096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2019
  • 负责人:
    Hamam, Habib
  • 依托单位:
国内基金
海外基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    程瑶
  • 依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
  • 批准号:
    JCZRQN202500319
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    仇凤启
  • 依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究